2009China Practical MedicineRequires access

Clinical curative effect of montelukast on cough variation asthma(cva) in children

XU Xiu-feng

Open publisher page 0 citations

Abstract

Objective To investigate the clinical curative effect of Montelukast taken orally on cough variation asthma(CVA)in children.Methods All the 50 examples aged from 6-14 years old diagnosed CVA were divided into treatment groupand control group randomly.The children in treatment group took Montelukast orally 1 time a day(5 mg/time)and inhaled Budesonide Aerosol qd(each time 1 spurt,content 200 μg),and those in control group inhaled Budesonide Aerosol bid(each time 1 spurt,content 200 μg)only.Both groups were observed for 8 weeks.The recurrence rate of CVA was also investigated at the follow-up of 6 months.side effects were recorded before and after treatment.Results Both of the groups could reduce symptoms such as cough,there was not different between the two groups after treatment.Conclusion Montelukast has positive effect on CVA in children and can reduce the dose used of the latter.

About this research paper

What this paper is about

Objective To investigate the clinical curative effect of Montelukast taken orally on cough variation asthma(CVA)in children.Methods All the 50 examples aged from 6-14 years old diagnosed CVA were divided into treatment groupand control group randomly.The children in treatment group took Montelukast orally 1 time a day(5 mg/time)and inhaled Budesonide Aerosol qd(each time 1 spurt,content 200 μg),and those in control group inhaled Budesonide Aerosol bid(each time 1 spurt,content 200 μg)only.Both groups were observed for 8 weeks.The recurrence rate of CVA was also investigated at the follow-up of 6 months.side effects were recorded before and after treatment.Results Both of the groups could reduce symptoms such as cough,there was not different between the two groups after treatment.Conclusion Montelukast has positive effect on CVA in children and can reduce the dose used of the latter.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical curative effect of Montelukast taken orally on cough variation asthma(CVA)in children.Methods All the 50 examples aged from 6-14 years old diagnosed CVA were divided into treatment groupand control group randomly.The children in treatment group took Montelukast orally 1 time a day(5 mg/time)and inhaled Budesonide Aerosol qd(each time 1 spurt,content 200 μg),and those in control group inhaled Budesonide Aerosol bid(each time 1 spurt,content 200 μg)only.Both groups were observed for 8 weeks.The recurrence rate of CVA was also investigated at the follow-up of 6 months.side effects were recorded before and after treatment.Results Both of the groups could reduce symptoms such as cough,there was not different between the two groups after treatment.Conclusion Montelukast has positive effect on CVA in children and can reduce the dose used of the latter.

Key concepts: Medicine, Montelukast, Budesonide, Asthma, Anesthesia, Inhalation, Pediatrics, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical curative effect of montelukast on cough variation asthma(cva) in children — Research Paper | ScholarLens